Changchun GeneScience Pharmaceutical Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1948-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://english.ciac.cas.cn/
A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome
- Conditions
- Turner Syndrome
- Interventions
- Biological: PEG-rhGH low doseBiological: PEG-rhGH high doseOther: Non-treatment control group
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2017-12-12
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 180
- Registration Number
- NCT03189160
- Locations
- 🇨🇳
The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China
🇨🇳Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi, China
🇨🇳Beijing Children's Hospital,Capital Medical University, Beijing, China
A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD
- First Posted Date
- 2017-04-07
- Last Posted Date
- 2017-04-07
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 180
- Registration Number
- NCT03104010
- Locations
- 🇨🇳
Heibei General Hospital, Shijiazhuang, Hebei, China
🇨🇳Qilu Hospital of Shandong University, Jinan, Shandong, China
🇨🇳West China Hospital, Sichuan University, Chengdu, Sichuan, China
Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET
- Conditions
- Ovarian Hyperstimulation Syndrome
- Interventions
- First Posted Date
- 2017-03-06
- Last Posted Date
- 2017-03-06
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 252
- Registration Number
- NCT03071172
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
🇨🇳Peking University Third Hospital, Beijing, China
🇨🇳The first Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
- Conditions
- Growth Hormone Deficiency
- Interventions
- Biological: PEG-somatropin
- First Posted Date
- 2016-11-29
- Last Posted Date
- 2017-06-16
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 600
- Registration Number
- NCT02976675
- Locations
- 🇨🇳
Maternal and Child Health Hospital of Guiyang City, Guiyangtou, Guizhou, China
🇨🇳Hebei Provincial People's Hospital, Shijiazhuang, Hebei, China
🇨🇳Maternal and Child Health Hospital of Anhui province, Hefei, Anhui, China
Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
- Conditions
- Growth Hormone Deficiency
- Interventions
- Biological: PEG-somatropin
- First Posted Date
- 2016-09-21
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 900
- Registration Number
- NCT02908958
- Locations
- 🇨🇳
The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
🇨🇳Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China
🇨🇳Qilu Children's Hospital of Shandong University, Jinan, Shandong, China
Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of POR in Patients Undergoing IVF/ET
- Conditions
- Poor Ovarian Response
- Interventions
- Procedure: Conventional ovarian stimulation proctol without rhGH
- First Posted Date
- 2016-06-16
- Last Posted Date
- 2016-06-16
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT02801591
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
🇨🇳People's Hospital of Peking University, Beijing, China
Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Drug: Conventional controlled ovarian stimulation proctol
- First Posted Date
- 2016-06-16
- Last Posted Date
- 2016-11-28
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 208
- Registration Number
- NCT02801565
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)
- Conditions
- Growth Hormone Deficiency
- Interventions
- Biological: PEG-somatropin
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2017-06-16
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 600
- Registration Number
- NCT02380235
- Locations
- 🇨🇳
Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, Beijing, China
🇨🇳Chinese Academy of Medical Sciences &Peking Union Medical College, Beijing, Beijing, China
🇨🇳Children's Hospital of Fudan University, Shanghai, Shanghai, China
Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature
- Conditions
- Small for Gestational Age Infant
- Interventions
- Biological: PEG-somatropin
- First Posted Date
- 2015-03-02
- Last Posted Date
- 2015-03-02
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 96
- Registration Number
- NCT02375620
- Locations
- 🇨🇳
Hunan Children's Hospital, Changsha, Hunan, China
🇨🇳Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China
🇨🇳First Hospital of Jilin University, Changchun, Jilin, China
Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation
- Conditions
- Anovulation
- Interventions
- Biological: Gonal-F
- First Posted Date
- 2015-01-12
- Last Posted Date
- 2015-01-12
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 534
- Registration Number
- NCT02335879